Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study

Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study

Abstract Background Studies have demonstrated that both lower limb arterial calcification and metabolic dysfunction-associated steatotic liver disease (MASLD) are linked to the development of peripheral artery disease. However, the potential relationship between MASLD biomarkers and progression of l...

Full description

Saved in:
Bibliographic Details
Main Authors: Damien Denimal, Maharajah Ponnaiah, Franck Phan, Anne-Caroline Jeannin, Alban Redheuil, Joe-Elie Salem, Samia Boussouar, Pauline Paulstephenraj, Suzanne Laroche, Chloé Amouyal, Agnès Hartemann, Fabienne Foufelle, Olivier Bourron
Format: Article
Language:English
Published: BMC 2025-04-01
Series:Cardiovascular Diabetology
Subjects:
Peripheral arterial disease
Type 2 diabetes mellitus
Liver fibrosis
Nonalcoholic fatty liver disease
Online Access:https://doi.org/10.1186/s12933-025-02705-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12933-025-02705-9

Similar Items